Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries LtdfiledCriticalTakeda Chemical Industries Ltd
Priority to JP8891583ApriorityCriticalpatent/JPS59216888A/ja
Priority to US06/510,723prioritypatent/US4539326A/en
Priority to EP83304208Aprioritypatent/EP0102175A1/de
Priority to CA000434690Aprioritypatent/CA1200243A/en
Publication of JPS59216888ApublicationCriticalpatent/JPS59216888A/ja
Publication of JPH0379357B2publicationCriticalpatent/JPH0379357B2/ja
N-Substituierte Omega-(2-oxo-imidazolin-1-yl)-alkansäuren, deren Salze und Ester, Verfahren zu deren Herstellung und diese aktiven Substanzen enthaltende pharmazeutische Zubereitungen
Novel 2-[4-(3-methyl-2-thienyl)phenyl]propionic acid and pharmaceutically acceptable salt thereof and method for treating symptoms of inflammation and pain
Verfahren zur Herstellung von Thieno (2,3-c)-bzw. (3,2-c) pyridinderivaten, so erhaltene Thieno (2,3-c) pyridinderivate und ihre therapeutische Anwendung